OP 2.3 – 00117 The EZH2 inhibitor Tazemetostat increases MHC I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs

Bibliographic Details
Title: OP 2.3 – 00117 The EZH2 inhibitor Tazemetostat increases MHC I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs
Authors: A. Gramatica, A. Danesh, I. Miller, J. Weiler, F. Khan, D. Copertino, U. Chukwukere, L. Leyre, B. Jones
Source: Journal of Virus Eradication, Vol 8, Iss , Pp 100151- (2022)
Publisher Information: Elsevier, 2022.
Publication Year: 2022
Collection: LCC:Microbiology
LCC:Public aspects of medicine
Subject Terms: Microbiology, QR1-502, Public aspects of medicine, RA1-1270
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2055-6640
Relation: http://www.sciencedirect.com/science/article/pii/S2055664022000899; https://doaj.org/toc/2055-6640
DOI: 10.1016/j.jve.2022.100151
Access URL: https://doaj.org/article/b25e1e0441f848138a50f0fb3aa62122
Accession Number: edsdoj.b25e1e0441f848138a50f0fb3aa62122
Database: Directory of Open Access Journals
More Details
ISSN:20556640
DOI:10.1016/j.jve.2022.100151
Published in:Journal of Virus Eradication
Language:English